Rajesh Shrotriya
Director/Miembro de la Junta en GT BIOPHARMA, INC. .
Fortuna: - $ al 30/04/2024
Cargos activos de Rajesh Shrotriya
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GT BIOPHARMA, INC. | Director/Miembro de la Junta | 13/01/2021 | - |
Independent Dir/Board Member | 13/01/2021 | - | |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Director/Miembro de la Junta | 05/09/2012 | - |
The UNLV Foundation
The UNLV Foundation Investment Trusts/Mutual FundsMiscellaneous The UNLV Foundation provides financial services. The non-profit company is based in Las Vegas, NV and has subsidiaries in United States. | Director/Miembro de la Junta | - | - |
Shrotriya Family Foundation
Shrotriya Family Foundation Investment Trusts/Mutual FundsMiscellaneous Shrotriya Family Foundation operates as a grant making foundation. The private company is based in Henderson. | Director/Miembro de la Junta | - | - |
Cs Family Trust | Director/Miembro de la Junta | - | - |
Spectrum Pharmaceuticals Cayman LP | Director/Miembro de la Junta | - | - |
Historial de carrera de Rajesh Shrotriya
Antiguos cargos conocidos de Rajesh Shrotriya.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SPECTRUM PHARMACEUTICALS, INC. | Director Ejecutivo | 01/08/2002 | 17/12/2017 |
Presidente | 01/08/2002 | 17/12/2017 | |
Director de Operaciones | 01/09/2000 | 01/08/2002 | |
Presidente | 01/09/2000 | 01/08/2002 | |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Director Técnico/Científico/I+D | 01/11/1996 | 01/08/2000 |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Director Técnico/Científico/I+D | 01/08/1994 | 01/10/1996 |
░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formación de Rajesh Shrotriya.
Armed Forces Medical College | Undergraduate Degree |
Dr. Bhim Rao Ambedkar University | Undergraduate Degree |
The Grant Government Medical College | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 13 |
India | 4 |
Islas Caimán | 2 |
Operativa
Director/Board Member | 9 |
Independent Dir/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Sectorial
Health Technology | 10 |
Consumer Services | 4 |
Miscellaneous | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
GT BIOPHARMA, INC. | Health Technology |
Empresas privadas | 10 |
---|---|
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
The UNLV Foundation
The UNLV Foundation Investment Trusts/Mutual FundsMiscellaneous The UNLV Foundation provides financial services. The non-profit company is based in Las Vegas, NV and has subsidiaries in United States. | Miscellaneous |
Shrotriya Family Foundation
Shrotriya Family Foundation Investment Trusts/Mutual FundsMiscellaneous Shrotriya Family Foundation operates as a grant making foundation. The private company is based in Henderson. | Miscellaneous |
Cs Family Trust | Miscellaneous |
Spectrum Pharmaceuticals Cayman LP | |
Theralink Technologies, Inc. (Colorado)
Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
- Bolsa de valores
- Insiders
- Rajesh Shrotriya
- Experiencia